Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

Clinical trial NCT03747224 · COMPLETED

Trial details

NCT number: NCT03747224
Sponsor: Arrowhead Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dyslipidemias Familial Hypercholesterolemia Hypertriglyceridemia

Start date: 2019-01-07
Primary completion: 2021-05-17
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.